Insider sale
INDIVIOR PHARMACEUTICALS, INC.
$6.62M
266.26K shares
What this filing means
CROSSLEY MARK plans to sell 266.26K shares of INDIVIOR PHARMACEUTICALS, INC. valued at approximately $6.62M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/8/2025ACC: 0001974494-25-000101
266.26K
Shares to sell
$6.62M
Approx. market value
243.28K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
Equity Compensation
3/9/2025
243.28KTotal acquired243.28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/9/2025 | Vesting of Restricted Stock Units Equity Compensation | 243.28K | — |
| Total | 243.28K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
30K
Market value
$744.0K
9/4/2025
—Completed
Units to sell
52.32K
Market value
$1.28M
8/28/2025
Planned — Approximate Date
NYSEPlanned
Units to sell
183.94K
Market value
$4.59M
9/8/2025
Total
Units
266.26K
Value
$6.62M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/4/2025 | 30K | $744.0K | — | Completed |
8/28/2025 | 52.32K | $1.28M | — | Completed |
| Planned — Approximate Date | ||||
9/8/2025 | 183.94K | $4.59M | NYSE | Planned |
| Total | 266.26K | $6.62M | ||